Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Edge Therapeutics, Inc. (NASDAQ: EDGE).

Full DD Report for EDGE

You must become a subscriber to view this report.


Recent News from (NASDAQ: EDGE)

EDGE EQUITY ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Edge Therapeutics, Inc. and a Lead Plaintiff Deadline of June 22, 2018
NEW YORK, NY / ACCESSWIRE / May 17, 2018 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Edge Therapeutics, Inc. ("Edge Therapeutics") (NASDAQ: EDGE) securities between ...
Source: ACCESSWIRE IA
Date: May, 17 2018 15:35
EDGE DEADLINE: Pawar Law Reminds Investors of Important June 22, 2018 Lead Plaintiff Deadline in Class Action- EDGE
NEW YORK, NY / ACCESSWIRE / May 17, 2018 / Pawar Law Group reminds shareholders who purchased shares of Edge Therapeutics, Inc. (NASDAQ: EDGE) from December 29, 2017 through March 27, 2018, both dates inclusive (the "Class Period") of the important June 22, 2018 lead plaintiff deadline in th...
Source: ACCESSWIRE IA
Date: May, 17 2018 13:55
IMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Edge Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 15, 2018 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Edge Therapeutics, Inc. (''Edge'' or ''the Company'') (NASDAQ: EDGE ) for violations of §§10(b) and 20(a) of t...
Source: ACCESSWIRE IA
Date: May, 15 2018 16:45
The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Edge Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of June 22, 2018 (EDGE)
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Edge Therapeutics, Inc. (NASDAQ: EDGE) who purchased shares between December 29, 2017 and March 27, 2018 . The action, which was filed in the USDC for the District of New Jersey, alleges...
Source: Business Wire
Date: May, 15 2018 15:00
Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Edge Therapeutics, Inc. (EDGE) and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the U.S. District Court for the District of New Jersey on behalf of all persons or entities who purchased or otherwise acquired Edge Therapeutics, Inc. (NASDAQ: EDGE) securities between ...
Source: Business Wire
Date: May, 14 2018 15:10
EDGE INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Edge Therapeutics, Inc. and a Lead Plaintiff Deadline of June 22, 2018
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Edge Therapeutics, Inc. ("Edge Therapeutics") (NASDAQ: EDGE) securities between December 29, 2017 and March 27, 2018 . ...
Source: Business Wire
Date: May, 14 2018 15:00
EDGE LOSS NOTICE: Rosen Law Reminds Edge Therapeutics, Inc. Investors of Important Deadline in Class Action - EDGE
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Edge Therapeutics, Inc. (NASDAQ: EDGE) from December 29, 2017 through March 27, 2018, both dates inclusive (the “Class Period”) of the important June 22, 2018 lead plaintiff deadline in t...
Source: Business Wire
Date: May, 11 2018 16:59
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Edge Therapeutics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 22, 2018
The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Edge Therapeutics, Inc. ("Edge Therapeutics") (NASDAQ:EDGE) between December 29, 2017 and March 27, 2018 . You are hereby notified ...
Source: Business Wire
Date: May, 11 2018 11:55
PAWAR LAW - Edge Therapeutics, Inc. - June 22, 2018 Deadline in Class Action - EDGE
NEW YORK, NY / ACCESSWIRE / May 10, 2018 / Pawar Law Group reminds shareholders who purchased shares of Edge Therapeutics, Inc. (NASDAQ: EDGE) from December 29, 2017 through March 27, 2018, both dates inclusive (the ''Class Period'') of the important June 22, 2018 lead plaintiff deadline in ...
Source: ACCESSWIRE IA
Date: May, 10 2018 17:10
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Edge Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 10, 2018 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Edge Therapeutics, Inc. (''Edge'' or ''the Company'') (NASDAQ: EDGE ) for violations of §§10(b) and 20(a) of t...
Source: ACCESSWIRE
Date: May, 10 2018 11:25

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-170.88920.85780.900.8572,283
2018-08-160.89010.880.900.8734,989
2018-08-150.860.89090.8960.805172,505
2018-08-140.880.8510.91790.851143,829
2018-08-130.91060.900.920.880160,454

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-171,75914,72211.9481Cover
2018-08-1612,26412,58297.4726Short
2018-08-1535,00769,78450.1648Short
2018-08-1413,75125,21454.5372Short
2018-08-134,76621,98621.6774Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on EDGE.


About Edge Therapeutics, Inc. (NASDAQ: EDGE)

Logo for Edge Therapeutics, Inc. (NASDAQ: EDGE)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $31,246,231 - 05/15/2018
  • Issue and Outstanding: 31,246,231 - 04/25/2018

 


Recent Filings from (NASDAQ: EDGE)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 01 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 01 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 01 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 30 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 25 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 25 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 25 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: April, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 29 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: March, 02 2018

 

 


Daily Technical Chart for (NASDAQ: EDGE)

Daily Technical Chart for (NASDAQ: EDGE)


Stay tuned for daily updates and more on (NASDAQ: EDGE)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: EDGE)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in EDGE is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of EDGE and does not buy, sell, or trade any shares of EDGE. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/